Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement. Complications from constipation may include hemorrhoids, anal fissure or fecal impaction. Constipation Pipeline Market Research Report provides the latest projects and drug profiles with key companies.
Introduction:
Constipation refers to the infrequent or difficult passing of stool. Constipation occurs when bowel movements become difficult or less frequent. Symptoms of constipation include swollen abdomen or abdominal pain, pain and vomiting. The predisposing factors include eating disorders, irritable bowel syndrome, and hypothyroidism, overuse of laxatives (stool softeners) which, over time, weaken the bowel muscles, stress, inadequate water intake and inadequate fiber in the diet. Treatment includes use of laxatives and proper lifestyle.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=911459 .
The Pharmaceutical and Healthcare latest pipeline guide Constipation Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Constipation (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Key Company Profiles:
Albireo Pharma Inc, Ardelyx Inc, Assembly Biosciences Inc, Astellas Pharma Inc, Braintree Laboratories Inc, CJ HealthCare Corp, Dong-A Socio Holdings Co Ltd, EA Pharma Co Ltd, Ironwood Pharmaceuticals Inc, Lipid Pharmaceuticals ehf, Motus Therapeutics Inc, NGM Biopharmaceuticals Inc, RaQualia Pharma Inc, Sanwa Kagaku Kenkyusho Co Ltd, Shire Plc, SK Biopharmaceuticals Co Ltd, Sucampo Pharmaceuticals Inc, Sumitomo Dainippon Pharma Co Ltd, Synthetic Biologics Inc, Torrent Pharmaceuticals Ltd, Yuhan Corp.
Constipation - Drug Profiles:
5-BIOP - Drug Profile, AJG-555 - Drug Profile, ASP-7663 - Drug Profile, Biologic for Irritable Bowel Syndrome with Constipation - Drug Profile, BLI-400 - Drug Profile, BLI-801 - Drug Profile, CJ-14199 - Drug Profile, DA-6886 - Drug Profile, DSP-6952 - Drug Profile, elobixibat - Drug Profile, ENT-01 - Drug Profile, J-027 - Drug Profile, linaclotide - Drug Profile, lovastatin - Drug Profile, LP-101 - Drug Profile, lubiprostone - Drug Profile, naronapride - Drug Profile, NGM-282 - Drug Profile.

Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=911459
Constipation (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Constipation (Gastrointestinal).
The pipeline guide reviews pipeline therapeutics for Constipation (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Constipation (Gastrointestinal) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Constipation (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Constipation (Gastrointestinal)
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=911459 .
Table of Contents:
Constipation - Overview
Constipation - Therapeutics Development
Constipation Pipeline Overview
Constipation Pipeline by Companies
Constipation - Therapeutics Assessment
Constipation - Companies Involved in Therapeutics Development
Constipation - Drug Profiles
Constipation - Dormant Projects
Constipation - Product Development Milestones and more…

List of Tables.
Number of Products under Development for Constipation, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Constipation - Pipeline by Assembly Biosciences Inc, H1 2017
Constipation - Pipeline by Astellas Pharma Inc, H1 2017
Constipation - Pipeline by Braintree Laboratories Inc, H1 2017
Constipation - Dormant Projects, H1 2017 and more…

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with your contact details.